Bastide, a prominent player in the home healthcare sector, has reported a steady growth in its home healthcare services, resulting in a year-on-year sales growth of 4.3% for the fiscal year 2023-2024, reaching a total of €529.8 million.
The company's Ebitda also increased by 5.9%, amounting to €107.6 million, with the Ebitda margin slightly rising to 20.3%. This positive momentum reflects Bastide's strategic focus on enhancing service quality and expanding its market reach.
The company remains optimistic about its future prospects, reaffirming its sales target of exceeding €560 million for the current financial year. Bastide's financial strategy aims to improve its recurring operating margin by 20 to 25 basis points, targeting a minimum of 8.7% by the fiscal year 2024-2025. The company is also prioritizing the reduction of debt and the improvement of its debt ratios.
Bastide's commitment to operational excellence is evident in its approach to managing costs while expanding its service offerings. By focusing on higher value-added activities, Bastide aims to increase revenue and enhance the quality of care provided.
The home healthcare market is experiencing significant changes, and Bastide's ability to adapt to these dynamics will be crucial for its continued success. The company's strategic initiatives are designed to leverage these trends and ensure it remains at the forefront of the industry.
Bastide's management expresses confidence in the company's ability to navigate potential challenges and seize new opportunities. With a solid foundation and a clear strategic vision, Bastide aims to strengthen its position as a leader in the home healthcare sector.